Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Osimertinib Shows Favorable Outcomes In Final OS Analysis Of NSCLC Patients Nov 17, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) ATZ-TBP Shows Favorable Benefit-risk Profile In Extensive-Stage SCLC Nov 17, 2023
Breast Cancer Ribociclib Plus Fulvestrant Improves Survival in Postmenopausal Women With HR+/HER2− Advanced Breast Cancer Nov 16, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Proves Effective In Advanced NSCLC Patients With METex 14 Mutations Nov 16, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Cabozantinib Shows Improved Outcomes Vs. Placebo For Advanced NET Nov 16, 2023